Passage Bio 8-K Filing - Apr 20

The Big Picture

Passage BIO filed an 8-K on Apr 20 reporting a Regulation FD disclosure and the submission of financial statements and exhibits, a reminder to investors to monitor formal disclosures from the company. This filing, logged with the SEC under accession number 0001104659-26-045219, does not by itself provide new operational metrics but affects disclosure tracking for portfolios with exposure to the company.

What's Happening

The company submitted an 8-K to the SEC that documents two named items. Below are the key filing details straight from the SEC record and why each point matters to you as an investor.

• Filed Date: 2026-04-20, confirming when the disclosure entered the public record and should be referenced for timeliness.
• CIK (Filer): 0001787297, identifying Passage BIO's SEC filer number for cross-referencing other filings.
• Accession Number: 0001104659-26-045219, the SEC index entry you can use to pull the full filing and exhibits.
• File Size: 6 MB, indicating the filing includes material exhibits or attachments beyond a short notice.
• Item 7.01: Regulation FD Disclosure, showing the company disclosed information under Reg FD protocols in this filing.
• Item 9.01: Financial Statements and Exhibits, indicating accompanying documentation or exhibits were filed with the 8-K.

Each of these filing elements matters because they tell you where to find the source documents, how substantial the filing package is, and that the notice was processed under Regulation FD and the SEC exhibits section. Investors tracking disclosure compliance or documentary updates should consult the accession number to review the exhibits directly.

Why It Matters For Your Portfolio

For shareholders and watchers of the company, this 8-K is primarily a disclosure event. It signals that the company has submitted formal material under Regulation FD and has included exhibits or financial statements, which could contain clarifying information or supporting documents relevant to prior announcements. If you hold exposure to Passage BIO, consider this filing as part of the company’s public record you may want to review.

Risks To Consider

• Incomplete Information Risk: The 8-K lists exhibits and statements but does not specify their contents in the SEC index header, so important details may still be found only within attached exhibits.
• Disclosure Follow-Up Risk: Regulation FD disclosure can precede or follow material announcements; subsequent filings or press releases could change investor context.
• Document Interpretation Risk: Exhibits and financial statements can include technical or legal language that affects interpretation, so relying solely on the index without reviewing attachments could be misleading.

What To Watch Next

Monitor the company’s filings and public statements for any follow-up that clarifies or expands on the items referenced in this 8-K. Key things to watch include official press releases, subsequent SEC filings referencing the accession number, and any investor communications that reference the exhibits.

• Check the full filing at accession number 0001104659-26-045219 to read Item 7.01 and Item 9.01 exhibits.
• Watch for additional SEC filings or press releases that reference the Apr 20 8-K.
• Review any attached financial statements or exhibits for disclosures that could affect valuation or risk assumptions.

The Bottom Line

• This 8-K, filed Apr 20, records a Regulation FD disclosure and the submission of financial statements and exhibits; it is a disclosure event rather than a detailed operational update.
• Use accession number 0001104659-26-045219 and filer CIK 0001787297 to access the full documents and exhibits for complete context.
• Investors should review the exhibits directly before making portfolio decisions, as the index header does not describe exhibit contents.
• Expect the filing to be relevant for compliance and disclosure monitoring; watch for follow-up filings or company statements for any material developments.

FAQ

Q: What did Passage BIO file in the 8-K?

A: The 8-K filed on 2026-04-20 lists Item 7.01, Regulation FD Disclosure, and Item 9.01, Financial Statements and Exhibits, and is available under accession number 0001104659-26-045219.

Q: Where can I find the full filing documents?

A: Use the SEC accession number 0001104659-26-045219 or the filer CIK 0001787297 to retrieve the complete 8-K and any attached exhibits from the SEC EDGAR database.

Q: Should I act on this filing now?

A: The 8-K records a disclosure and attached exhibits; you should review the exhibits for substantive details before adjusting positions and monitor for any follow-up statements or filings.